新型冠状病毒肺炎疫情形势下原发性肝癌破裂出血的诊治策略

Diagnosis and treatment strategies for rupture and hemorrhage of primary liver cancer under the epidemic situation of novel coronavirus pneumonia

在新型冠状病毒肺炎(简称:新冠肺炎;WHO定名:COVID-19)疫情下,如何处理危及患者生命的原发性肝癌(简称肝癌)破裂出血是目前临床上亟需解决的问题之一。笔者认为,该病的临床处置应在筛查新冠肺炎的前提下,遵循操作流程,做好充分防护。对于疑似或确诊新冠肺炎患者,需综合考虑新冠肺炎分型、肝癌破裂出血的程度、肿瘤情况、肝功能情况等因素,慎重制定具体治疗方案,开展个体化治疗。遵从既保证患者的安全及疗效,又要降低医护人员感染风险的诊治原则。

In period of the epidemic of novel coronavirus pneumonia (NCP;WHO named as COVID-19),how to deal with the life-threatening rupture and hemorrhage of the primary liver cancer (PLC) is one of the urgent clinical problems that have to be solved.The authors think that the treatment of this condition must be undertaken by following the standard operating procedures and with sufficient prevention and protection based on the premise of COVID-19 screening.For those with suspected or confirmed COVID-19,the treatment scenarios should be carefully designed and approaches should be tailored to individual patient based on the integrated consideration of the clinical classification of COVID-19,the degree of rupture and hemorrhage of PLC as well as the tumor and liver function conditions.The general principle is that not only the safety and efficacy must be guaranteed to the patients,and the infectious risks also should be minimized to the healthcare workers.